Osaic Holdings’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.2K | Buy |
5,849
+1,300
| +29% | +$3.15K | ﹤0.01% | 5553 |
|
2025
Q1 | $9.73K | Sell |
4,549
-1,400
| -24% | -$3K | ﹤0.01% | 5744 |
|
2024
Q4 | $14.4K | Buy |
5,949
+2,100
| +55% | +$5.08K | ﹤0.01% | 5515 |
|
2024
Q3 | $9.39K | Hold |
3,849
| – | – | ﹤0.01% | 5773 |
|
2024
Q2 | $9.89K | Sell |
3,849
-800
| -17% | -$2.06K | ﹤0.01% | 5726 |
|
2024
Q1 | $13.6K | Sell |
4,649
-3,730
| -45% | -$10.9K | ﹤0.01% | 5522 |
|
2023
Q4 | $19.4K | Sell |
8,379
-11,300
| -57% | -$26.1K | ﹤0.01% | 5495 |
|
2023
Q3 | $51.4K | Buy |
19,679
+3,440
| +21% | +$8.98K | ﹤0.01% | 4982 |
|
2023
Q2 | $58.1K | Sell |
16,239
-1,817
| -10% | -$6.51K | ﹤0.01% | 4837 |
|
2023
Q1 | $39.3K | Sell |
18,056
-4,403
| -20% | -$9.59K | ﹤0.01% | 5102 |
|
2022
Q4 | $270K | Sell |
22,459
-2,242
| -9% | -$27K | ﹤0.01% | 3597 |
|
2022
Q3 | $161K | Buy |
24,701
+5,498
| +29% | +$35.8K | ﹤0.01% | 3950 |
|
2022
Q2 | $88K | Buy |
19,203
+2,849
| +17% | +$13.1K | ﹤0.01% | 4522 |
|
2022
Q1 | $137K | Sell |
16,354
-9,913
| -38% | -$83K | ﹤0.01% | 4336 |
|
2021
Q4 | $375K | Buy |
26,267
+8,697
| +49% | +$124K | ﹤0.01% | 3348 |
|
2021
Q3 | $386K | Buy |
17,570
+9,982
| +132% | +$219K | ﹤0.01% | 3299 |
|
2021
Q2 | $101K | Buy |
7,588
+2,863
| +61% | +$38.1K | ﹤0.01% | 4471 |
|
2021
Q1 | $48K | Buy |
4,725
+3,725
| +373% | +$37.8K | ﹤0.01% | 4901 |
|
2020
Q4 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 5797 |
|
2020
Q2 | – | Sell |
-1,000
| Closed | -$3K | – | 6143 |
|
2020
Q1 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 5480 |
|